{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:20:55Z","timestamp":1791228055532,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2181,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2885.2009.01130.x","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T06:16:42Z","timestamp":1252649802000},"page":"260-267","source":"Crossref","is-referenced-by-count":21,"title":["A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog"],"prefix":"10.1111","volume":"33","author":[{"given":"J.","family":"GUYONNET","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"ELLIOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"KALTSATOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,11]]},"reference":[{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circulation Research"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB2|cit2","unstructured":"EMEA - European Medicines Agency - Veterinary Medicines 2007 Prilactone\u00ae431 http:\/\/www.emea.europa.eu\/vetdocs\/PDFs\/EPAR\/prilactone\/V-105-PI-en.pdf"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB6|cit3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"Haggstrom","year":"1996","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB7|cit4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3565(25)30273-9","article-title":"Potassium prorenoate: a new steroidal aldosterone antagonist","volume":"194","author":"Hofmann","year":"1975","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB8|cit5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3565(25)30916-X","article-title":"Mexrenoate potassium: a steroidal aldosterone antagonist and antihypertensive","volume":"201","author":"Hofmann","year":"1977","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB9|cit6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jvc.2007.10.002","article-title":"Effect of pironolactone on diuresis and urine sodium and potassium excretion in healthy dogs","volume":"9","author":"Jeunesse","year":"2007","journal-title":"Journal of Veterinary Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB10|cit7","first-page":"189","volume-title":"Design and Analysis of Cross-Over Trials","author":"Jones","year":"1998"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB11|cit8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3181\/00379727-115-29052","article-title":"Relationship of plasma aldadiene levels and antimineralocorticoid. Effects of spironolactone in the laboratory","volume":"115","author":"Kagawa","year":"1964","journal-title":"Proceeding of the Society for Experimental Biology and Medicine"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB12|cit9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpcardio0914","article-title":"Drug insight: aldosterone-receptor antagonists in heart failure - the journey continues","volume":"4","author":"Kalidindi","year":"2007","journal-title":"Nature Clinical Practice Cardiovascular Medicine"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB13|cit10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0090-9556(25)06095-7","article-title":"Species differences in the metabolism and disposition of spironolactone","volume":"4","author":"Karim","year":"1976","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB14|cit11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2460\/javma.1983.183.09.991","article-title":"Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure","volume":"183","author":"Knowlen","year":"1983","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB15|cit12","volume-title":"Developpement and Validation of the Method of Spironolactone and its Metabolites in Plasma of Dogs","author":"Monnoyer","year":"2003"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB16|cit13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1939-1676.2003.tb02431.x","article-title":"Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation","volume":"17","author":"Pedersen","year":"2003","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB17|cit14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"Escape\u201d of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB18|cit15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB19|cit16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB20|cit17","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jps.2600610721","article-title":"Disposition of Tritium-labeled spironolactones in the dog","volume":"61","author":"Sadee","year":"1972","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB21|cit18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejheart.2004.04.013","article-title":"The clinical implications of aldosterone escape in congestive heart failure","volume":"6","author":"Struthers","year":"2004","journal-title":"European Journal of Heart Failure"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB22|cit19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2004.05.004","article-title":"Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy","volume":"96","author":"Tan","year":"2004","journal-title":"International Journal of Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB23|cit20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system atrial natriuretic peptide activity, and thyroid hormone concentration in dogs","volume":"62","author":"Tilholm","year":"2001","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB24|cit21","article-title":"Pharmacokinetics\/pharmacodynamics integration in drug development and dosage regimen optimization for veterinary medicine","volume":"4","author":"Toutain","year":"2002","journal-title":"American Association of Pharmaceutical Scientists"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB25|cit22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1389557054553811","article-title":"Molecular mechanisms of mineralocorticoid receptor antagonist by Eplerenone","volume":"5","author":"Xiao","year":"2005","journal-title":"Mini-Rewiews in Medicinal Chemistry"},{"key":"10.1111\/j.1365-2885.2009.01130.x-BIB26|cit23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"Journal of Pharmacokinetics Biopharmaceutics"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2009.01130.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2885.2009.01130.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:11:12Z","timestamp":1739329872000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2009.01130.x"}},"subtitle":["An approach to determine a dose of spironolactone"],"short-title":[],"issued":{"date-parts":[[2009,9,11]]},"references-count":23,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2009.01130.x","relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,11]]}}}